A study to evaluate the safety and efficacy of a test product in female subjects with varied skin type.
- Registration Number
- CTRI/2023/10/059282
- Lead Sponsor
- DPKA Universal Consumer Ventures Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 96
1) Subjects with dry / normal / oily / sensitive skin.
oSubjects with self-perceived normal skin.
oSubjects with dry (readings between 30 – 40) as assessed by MoistureMeterSC.
oSubjects with oily skin having Sebumeter measurement > 150 (µg/cm2).
oSubjects with sensitive skin based on Dr. Baumann’s skin type questionnaire.
2) Subjects having good general health as determined by the Investigator on the basis of medical history.
3) Females of Childbearing potential must have a negative urine pregnancy test performed during Visit 01.
1) Subjects undergoing treatment for skin lightening or subjects using other marketed skin lightening products during the study period or in the past 6 weeks.
2) Subjects who are receiving topical or systemic treatments.
3) Subjects receiving medications (e.g., steroids or antihistamines) would compromise the study.
4) Chronic illness which may influence the cutaneous state.
5) Subjects having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method